Cell line name | LAPC-4-EnzR |
---|---|
Accession | CVCL_RA56 |
Resource Identification Initiative | To cite this cell line use: LAPC-4-EnzR (RRID:CVCL_RA56) |
Comments | Selected for resistance to: ChEBI; CHEBI:68534; Enzalutamide (Xtandi; MDV-3100). Omics: Transcriptome analysis. |
Sequence variations |
|
Disease | Prostate carcinoma (NCIt: C4863) Derived from metastatic site: Lymph node. |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy | Parent: CVCL_4744 (LAPC-4) |
Sex of cell | Male |
Age at sampling | Age unspecified |
Category | Cancer cell line |
Publications | PubMed=27036029; DOI=10.18632/oncotarget.8456 |
Cross-references | |
Encyclopedic resources | Wikidata; Q54901926 |
Gene expression databases | GEO; GSM2069514
GEO; GSM2069515 GEO; GSM2069516 GEO; GSM2069517 |
Entry history | |
Entry creation | 05-Mar-2018 |
Last entry update | 20-May-2021 |
Version number | 5 |